-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Community-acquired pneumonia (CAP) is the leading cause of adult infections worldwide and is associated with high hospitalization rates and length of stay (LOS)
.
Recently, a research article was published in Critical Care, an authoritative journal in the field of critical care medicine, which aims to investigate the impact of type 2 diabetes (T2DM) on severe community-acquired pneumonia (SCAP) and develop a new type of SCAP for T2DM patients The prediction model of mortality
.
This is a retrospective observational study in which researchers analyzed adult SCAP patients who were admitted to the Intensive Care Unit (ICU) of West China Hospital of Sichuan University from September 2011 to September 2019
.
The main outcome of the study was the hospital mortality of the subjects
After PSM, the study included a total of 1262 SCAP patients with T2DM and 2524 matched patients without T2DM
.
Patients with T2DM have longer ICU hospital stays (LOS) (13 days vs.
Compared with non-diabetic patients, SCAP patients with T2DM have worse clinical outcomes
.
The nomogram has a good predictive performance for hospital mortality
Compared with non-diabetic patients, SCAP patients with T2DM have worse clinical outcomes
Original source:
Dong Huang,et al.
Clinical characteristics and risk factors associated with mortality in patients with severe community-acquired pneumonia and type 2 diabetes mellitus in this message